TrialEuropean stroke journal2023

Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH).

Adrian R Parry-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.